Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infection

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 5, 2010, Pages 1785-1792

  Propst, Katie L ^a   Troyer, Ryan M ^a   Kellihan, Lisa M ^a   Schweizer, Herbert P ^a   Dow, Steven W ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFTAZIDIME; RECOMBINANT GAMMA INTERFERON;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL GROWTH; BURKHOLDERIA PSEUDOMALLEI; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; DRUG POTENTIATION; FEMALE; IN VIVO STUDY; LOW DRUG DOSE; MACROPHAGE; MELIOIDOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; AVIAN PROTEINS; BURKHOLDERIA PSEUDOMALLEI; CEFTAZIDIME; CELL DIVISION; CYTOKINES; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; MACROPHAGES; MELIOIDOSIS; MICE; MICE, INBRED BALB C;

EID: 77951235249     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01513-09     Document Type: Article

References (33)

1. Arjcharoen, S., C. Wikraiphat, M. Pudla, K. Limposuwan, D. E. Woods, S. Sirisinha, and P. Utaisincharoen. 2007. Fate of a Burkholderia pseudomallei lipopolysaccharide mutant in the mouse macrophage cell line RAW 264.7: possible role for the O-antigenic polysaccharide moiety of lipopolysaccharide in internalization and intracellular survival. Infect. Immun. 75:4298-4304.
2. Cheng, A. C., and B. J. Currie. 2005. Melioidosis: epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 18:383-416.
3. Cheng, A. C., P. Dasari, and B. J. Currie. 2004. Granulocyte colony-stimulating factor and an in vitro whole blood model of melioidosis. Eur. J. Clin. Microbiol. Infect. Dis. 23:205-207.
4. Cheng, A. C., D. P. Stephens, N. M. Anstey, and B. J. Currie. 2004. Adjunctive granulocyte colony-stimulating factor for treatment of septic shock due to melioidosis. Clin. Infect. Dis. 38:32-37.
5. Clemons, K. V., E. Brummer, and D. A. Stevens. 1994. Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob. Agents Chemother. 38:460-464.
6. Currie, B. J., D. A. Dance, and A. C. Cheng. 2008. The global distribution of Burkholderia pseudomallei and melioidosis: an update. Trans. R. Soc. Trop. Med. Hyg. 102(Suppl. 1):S1-S4.
7. Dance, D. A. 2002. Melioidosis. Curr. Opin. Infect. Dis. 15:127-132.
8. DeShazer, D., P. J. Brett, R. Carlyon, and D. E. Woods. 1997. Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: isolation of motility mutants and molecular characterization of the flagellin structural gene. J. Bacteriol. 179:2116-2125.
9. Doherty, T. M., and A. Sher. 1998. IL-12 promotes drug-induced clearance of Mycobacterium avium infection in mice. J. Immunol. 160:5428-5435.
10. Dow, S. W., L. G. Fradkin, D. H. Liggitt, A. P. Willson, T. D. Heath, and T. A. Potter. 1999. Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously. J. Immunol. 163:1552-1561.
11. Easton, A., A. Haque, K. Chu, R. Lukaszewski, and G. J. Bancroft. 2007. A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei. J. Infect. Dis. 195:99-107.
12. Goodyear, A., L. Kellihan, H. Bielefeldt-Ohmann, R. Troyer, K. Propst, and S. Dow. 2009. Protection from pneumonic infection with Burkholderia species by inhalational immunotherapy. Infect. Immun. 77:1579-1588.
13. Gowen, B. B., J. Fairman, D. F. Smee, M. H. Wong, K. H. Jung, A. M. Pace, M. L. Heiner, K. W. Bailey, S. W. Dow, and R. W. Sidwell. 2006. Protective immunity against acute phleboviral infection elicited through immunostimulatory cationic liposome-DNA complexes. Antiviral Res. 69:165-172.
14. Herrmann, J. L., N. Dubois, M. Fourgeaud, D. Basset, and P. H. Lagrange. 1994. Synergic inhibitory activity of amphotericin-B and gamma interferon against intracellular Cryptococcus neoformans in murine macrophages. J. Antimicrob. Chemother. 34:1051-1058.
15. Jones, A. L., T. J. Beveridge, and D. E. Woods. 1996. Intracellular survival of Burkholderia pseudomallei. Infect. Immun. 64:782-790.
16. Leelarasamee, A. 2004. Recent development in melioidosis. Curr. Opin. Infect. Dis. 17:131-136.
17. Limmathurotsakul, D., W. Chaowagul, W. Chierakul, K. Stepniewska, B. Maharjan, V. Wuthiekanun, N. J. White, N. P. Day, and S. J. Peacock. 2006. Risk factors for recurrent melioidosis in northeast Thailand. Clin. Infect. Dis. 43:979-986.
18. Miyagi, K., K. Kawakami, and A. Saito. 1997. Role of reactive nitrogen and oxygen intermediates in gamma interferon-stimulated murine macrophage bactericidal activity against Burkholderia pseudomallei. Infect. Immun. 65:4108-4113.
19. Mouton, J. W., A. M. Horrevorts, P. G. Mulder, E. P. Prens, and M. F. Michel. 1990. Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers. Antimicrob. Agents Chemother. 34:2307-2311.
20. Onyeji, C. O., K. Q. Bui, D. P. Nicolau, C. H. Nightingale, L. Bow, and R. Quintiliani. 1999. Influence of adjunctive interferon-gamma on treatment of gentamicin- and vancomycin-resistant Enterococcus faecalis infection in mice. Int. J. Antimicrob. Agents 12:301-309.
21. Onyeji, C. O., D. P. Nicolau, C. H. Nightingale, and L. Bow. 1999. Interferongamma effects on activities of gentamicin and vancomycin against Enterococcus faecalis resistant to the drugs: an in vitro study with human neutrophils. Int. J. Antimicrob. Agents 11:31-37.
22. Pammit, M. A., V. N. Budhavarapu, E. K. Raulie, K. E. Klose, J. M. Teale, and B. P. Arulanandam. 2004. Intranasal interleukin-12 treatment promotes antimicrobial clearance and survival in pulmonary Francisella tularensis subsp. novicida infection. Antimicrob. Agents Chemother. 48:4513-4519.
23. Peacock, S. J. 2006. Melioidosis. Curr. Opin. Infect. Dis. 19:421-428.
24. Peacock, S. J., H. P. Schweizer, D. A. Dance, T. L. Smith, J. E. Gee, V. Wuthiekanun, D. DeShazer, I. Steinmetz, P. Tan, and B. J. Currie. 2008. Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei. Emerg. Infect. Dis. 14:e2.
25. Pitt, T. L., S. Trakulsomboon, and D. A. Dance. 2007. Recurrent melioidosis: possible role of infection with multiple strains of Burkholderia pseudomallei. J. Clin. Microbiol. 45:680-681.
26. Powell, K., G. Ulett, R. Hirst, and R. Norton. 2003. G-CSF immunotherapy for treatment of acute disseminated murine melioidosis. FEMS Microbiol. Lett. 224:315-318.
27. Slinker, B. K. 1998. The statistics of synergism. J. Mol. Cell. Cardiol. 30: 723-731.
28. Troyer, R. M., K. L. Propst, J. Fairman, C. M. Bosio, and S. W. Dow. 2009. Mucosal immunotherapy for protection from pneumonic infection with Francisella tularensis. Vaccine 27:4424-4433.
29. Ulett, G. C., R. Hirst, B. Bowden, K. Powell, and R. Norton. 2003. A comparison of antibiotic regimens in the treatment of acute melioidosis in a mouse model. J. Antimicrob. Chemother. 51:77-81.
30. Ulett, G. C., R. E. Norton, and R. G. Hirst. 1999. Combination antimicrobial therapy of acute Burkholderia pseudomallei infection in a mouse model. Pathology 31:264-267.
31. Utaisincharoen, P., N. Tangthawornchaikul, W. Kespichayawattana, P. Chaisuriya, and S. Sirisinha. 2001. Burkholderia pseudomallei interferes with inducible nitric oxide synthase (iNOS) production: a possible mechanism of evading macrophage killing. Microbiol. Immunol. 45:307-313.
32. Wiersinga, W. J., T. van der Poll, N. J. White, N. P. Day, and S. J. Peacock. 2006. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat. Rev. Microbiol. 4:272-282.
33. Wongratanacheewin, S., W. Kespichayawattana, P. Intachote, S. Pichyangkul, R. W. Sermswan, A. M. Krieg, and S. Sirisinha. 2004. Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei. Infect. Immun. 72:4494-4502.